|Articles|February 15, 2022

Pharm Exec E-Books

  • Pharm Exec E-Books-03-08-2021
  • Volume Sponsored eBook
  • Issue 2

The Next Domino: Automation, AI, and touchless safety case processing

Author(s)Oracle

With the increasing volumes of adverse event reports and stagnant budgets, the time is now for a revolutionary change in drug and device safety case management. A robust management process is necessary for identifying and evaluating adverse events (AE) and reporting them properly to regulators.


Related to this article

Pharmaceutical Executive daily
argenx acquires Unnatural Products for up to $1.15 billion to expand its immunology capabilities, GiftHealth’s Chip Parkinson on how single-partner platforms can transform the prescription journey, and Partha Anbil on why competing on net value matters more than cutting list prices as US drug pricing resets.